J Neurol Surg B Skull Base
DOI: 10.1055/a-2599-4262
Original Article

Association between Objective and Subjective Olfactory Dysfunction in SARS-CoV-2-Positive Patients Undergoing Skull Base Surgery

1   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic Florida, Jacksonville, Florida, United States
,
1   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic Florida, Jacksonville, Florida, United States
,
Natasha N. Najmi
1   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic Florida, Jacksonville, Florida, United States
,
Alaa Alhalabi
1   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic Florida, Jacksonville, Florida, United States
,
Kaisorn Chaichana
2   Department of Neurological Surgery, Mayo Clinic Florida, Jacksonville, Florida, United States
,
Angela M. Donaldson
1   Department of Otolaryngology – Head and Neck Surgery, Mayo Clinic Florida, Jacksonville, Florida, United States
› Author Affiliations

Abstract

Objective

This study aimed to investigate the association between objective and subjective olfactory assessments in patients with recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection undergoing endoscopic endonasal skull base surgery (EESBS).

Design

Retrospective cohort study.

Setting

Academic medical center.

Participants

Adult patients with and without recent SARS-CoV-2 infection who underwent EESBS for sellar and parasellar lesion resection between 2020 and 2024 at the Mayo Clinic in Florida, Jacksonville, FL.

Main Outcome Measures

Pre- and postoperative self-reported olfactory dysfunction and University of Pennsylvania Smell Identification Test (UPSIT) scores were collected.

Results

Patients with recent SARS-CoV-2 infection had a similar rate of discrepant preoperative objective olfactory assessments (38.2%, 26/68) compared with SARS-CoV-2-negative patients (39.9%, 127/318). SARS-CoV-2-positive patients were twice as likely to report postoperative subjective olfactory dysfunction (46.2%, 12/26) compared with SARS-CoV-2-negative patients (18.1%, 23/127, p = 0.002). There was no statistically significant difference in the mean preoperative (p = 0.162) or postoperative (p = 0.724) UPSIT scores between both groups.

Conclusion

Patients with recent SARS-CoV-2 infection and discrepant preoperative objective olfactory assessments were twice as likely to self-report olfactory dysfunction following EESBS compared with SARS-CoV-2-negative controls. This increase in self-reported olfactory dysfunction was not accompanied by changes in objective psychophysical testing. These findings suggest that SARS-CoV-2 infection may impact subjective olfactory recovery following EESBS.

Previous Presentation

The findings from this study were presented as a podium presentation at the NASBS 34th Annual Meeting and 9th World Congress of the World Federation of Skull Base Societies, held in New Orleans, LA, from February 13–16, 2025.




Publication History

Received: 12 March 2025

Accepted: 29 April 2025

Article published online:
23 May 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Ho CY, Salimian M, Hegert J. et al. Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19. JAMA Neurol 2022; 79 (06) 544-553
  • 2 Hannum ME, Ramirez VA, Lipson SJ. et al. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: A systematic review and meta-analysis. Chem Senses 2020; 45 (09) 865-874
  • 3 von Bartheld CS, Hagen MM, Butowt R. Prevalence of chemosensory dysfunction in COVID-19 patients: A systematic review and meta-analysis reveals significant ethnic differences. ACS Chem Neurosci 2020; 11 (19) 2944-2961
  • 4 Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: A rapid quantitative olfactory function test for the clinic. Laryngoscope 1984; 94 (2 Pt 1): 176-178
  • 5 Kahilogullari G, Beton S, Al-Beyati ES. et al. Olfactory functions after transsphenoidal pituitary surgery: endoscopic versus microscopic approach. Laryngoscope 2013; 123 (09) 2112-2119
  • 6 Zhu J, Feng K, Tang C. et al. Olfactory outcomes after endonasal skull base surgery: A systematic review. Neurosurg Rev 2021; 44 (04) 1805-1814
  • 7 Chou CT, Valappil B, Mattos JL. et al. The effect of nasoseptal flap elevation on post-operative olfaction and sinonasal quality of life: A prospective double-blinded randomized controlled trial. Am J Rhinol Allergy 2021; 35 (03) 353-360
  • 8 Griffiths CF, Barkhoudarian G, Cutler A. et al. Analysis of olfaction after bilateral nasoseptal rescue flap transsphenoidal approach with olfactory mucosal preservation. Otolaryngol Head Neck Surg 2019; 161 (05) 881-889
  • 9 Lee CC, Huang CC, Lee TJ. et al. Olfaction after endoscopic surgery for sellar and parasellar disease: an updated systematic review and meta-analysis. Rhinology 2022; 60 (03) 177-187
  • 10 Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: A biomarker for COVID-19. Int Forum Allergy Rhinol 2020; 10 (08) 944-950
  • 11 Lechien JR, Cabaraux P, Chiesa-Estomba CM. et al. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck 2020; 42 (07) 1583-1590
  • 12 Vaira LA, Deiana G, Fois AG. et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck 2020; 42 (06) 1252-1258
  • 13 Seok J, Shim YJ, Rhee CS, Kim JW. Correlation between olfactory severity ratings based on olfactory function test scores and self-reported severity rating of olfactory loss. Acta Otolaryngol 2017; 137 (07) 750-754
  • 14 Liu DT, Besser G, Prem B. et al. Association between orthonasal olfaction and chemosensory perception in patients with smell loss. Laryngoscope 2020; 130 (09) 2213-2219
  • 15 Desiato VM, Levy DA, Byun YJ, Nguyen SA, Soler ZM, Schlosser RJ. The prevalence of olfactory dysfunction in the general population: A systematic review and meta-analysis. Am J Rhinol Allergy 2021; 35 (02) 195-205
  • 16 Jang SS, Choi JS, Kim JH, Kim N, Ference EH. Discordance between subjective and objective measures of smell and taste in US adults. Otolaryngol Head Neck Surg 2022; 166 (03) 572-579
  • 17 Cao Z, Yang A, D'Aloisio AA. et al. Assessment of self-reported sense of smell, objective testing, and associated factors in middle-aged and older women. JAMA Otolaryngol Head Neck Surg 2022; 148 (05) 408-417
  • 18 Klarendic M, Zupanic E, Zalaznik M, Georgiev D, Tomazic J, Kojovic M. Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: A single-centre experience on 55 cases. Postgrad Med J 2022; 98 (1166) 902-905
  • 19 Butowt R, Bilinska K, Von Bartheld CS. Chemosensory dysfunction in COVID-19: Integration of genetic and epidemiological data points to D614G Spike protein variant as a contributing factor. ACS Chem Neurosci 2020; 11 (20) 3180-3184
  • 20 Abbasoglu B, Basak H, Mete B. et al. Effect of endoscopic endonasal skull base approaches on olfactory function and facial development in children. Childs Nerv Syst 2024; 40 (11) 3777-3788
  • 21 Jensen MM, Larsen KD, Homøe AS. et al. Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results. PLoS ONE 2022; 17 (10) e0275518